| P50 | author | Pierre Layrolle | Q38360448 |
| P2093 | author name string | Kamal Mustafa | |
| | Jan E Brinchmann | |
| | Tommy A Karlsen | |
| | Samih Mohamed-Ahmed | |
| | Daniela E Costea | |
| | Jerome Amiaud | |
| | Salwa Suliman | |
| | Hassan R W Ali | |
| P2860 | cites work | Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells | Q28176681 |
| | Oct4 is required for primordial germ cell survival | Q28594875 |
| | Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells | Q28729211 |
| | Replicative senescence of mesenchymal stem cells: a continuous and organized process | Q33336408 |
| | Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway | Q33390267 |
| | The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells | Q33660870 |
| | Density gradient centrifugation compromises bone marrow mononuclear cell yield | Q34510325 |
| | Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. | Q34852295 |
| | Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow | Q35100235 |
| | Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology | Q35216061 |
| | Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale | Q35418139 |
| | Human mesenchymal stem cells - current trends and future prospective | Q35548329 |
| | Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate | Q35652081 |
| | The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. | Q36715937 |
| | Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med | Q36775037 |
| | Human-derived alternatives to fetal bovine serum in cell culture. | Q37513950 |
| | Clinical applications of mesenchymal stem cells | Q38122364 |
| | Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures | Q38272362 |
| | Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? | Q38631723 |
| | Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche | Q38746020 |
| | Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells. | Q40013226 |
| | Evaluation of human platelet lysate and dimethyl sulfoxide as cryoprotectants for the cryopreservation of human adipose-derived stem cells | Q40120957 |
| | Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females | Q40306429 |
| | Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions | Q40821352 |
| | Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. | Q42236941 |
| | "Humanized" stem cell culture techniques: the animal serum controversy | Q42735346 |
| | Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells | Q42914079 |
| | Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy | Q43251718 |
| | Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications | Q43898390 |
| | CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells | Q44684687 |
| | Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c | Q44998864 |
| | Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells | Q45417013 |
| | Generation of a pool of human platelet lysate and efficient use in cell culture. | Q45992553 |
| | Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering | Q46308801 |
| | Xeno-Free Strategies for Safe Human Mesenchymal Stem/Stromal Cell Expansion: Supplements and Coatings | Q47151826 |
| | CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects. | Q47161696 |
| | Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. | Q47386441 |
| | Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. | Q50541811 |
| | In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. | Q51378561 |
| | Phenotypic characterization of distinct human bone marrow-derived MSC subsets. | Q53368111 |
| | Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. | Q55432734 |
| | Defined serum- and xeno-free cryopreservation of mesenchymal stem cells | Q57094520 |
| | Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial | Q58793452 |
| | Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors | Q64243123 |
| | Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow | Q73762259 |
| | Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice | Q85593180 |
| | Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach | Q92526186 |
| | HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study | Q92727720 |
| | Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion cultures | Q93191163 |
| | Expression of inflammatory cytokines in mesenchymal stromal cells is sensitive to culture conditions and simple cell manipulations | Q93368968 |
| P433 | issue | 1 | |
| P304 | page(s) | 16031 | |
| P577 | publication date | 2019-11-05 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Impact of humanised isolation and culture conditions on stemness and osteogenic potential of bone marrow derived mesenchymal stromal cells | |
| P478 | volume | 9 | |